|Day Low/High||130.45 / 134.39|
|52 Wk Low/High||121.00 / 148.99|
Here's list of key companies reporting earnings the week of October 14, 2019.
Jim Cramer explains the unexpected: quarterly results are 'not as bad as feared' -- NABAF. It's boosting stocks that, based on the headlines, should really just crumple.
Thursday's session was mixed, but we saw some decent statistics such as terrific breadth and more new highs.
I have the answer behind the conundrum that forces stocks up that should be going lower.
Jim discusses this morning's interview with Larry Kudlow, yesterday's with Marc Benioff, Johnson & Johnson, and Honeywell's earnings.
These stocks's earnings were 'not as bad as feared,' and here are some more names that pushed the NABAF narrative.
Stocks finish down as investors divide their attention between strong third-quarter earnings and concerns over weak U.S. retail sales and the ongoing U.S.-China trade war.
There are plenty of senior growth companies that can still move higher.
Johnson & Johnson extended gains Wednesday amid reports it could be close to agreeing a multi-billion dollar settlement with state attorneys general over its role in the nation's opioid crisis.
Global stocks traded mixed Wednesday, with modest gains in Asia offset by weaker U.S. equity futures, as investors eyed the final hours of Brexit negotiations between Britain and the EU while awaiting around round of third quarter earnings reports on Wall Street.
U.S. stock futures decline as Wall Street awaits another round of third-quarter earnings reports and global stocks trade mixed as investors monitored Brexit developments; Netflix, IBM and Bank of America report earnings Wednesday; McKesson, AmerisourceBergen and Cardinal Health reportedly are in talks to pay $18 billion to settle thousands of opioid-related lawsuits.
Stocks finish near record highs Tuesday as strong earnings reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson override investors' lingering questions about the fate of U.S.-China trade talks.
On days like today you realize how much of this market has been mauled by the bear.
Here are two and a half sectors to pay attention to during the earnings season. Hint: one has heavy exposure to China.
This strong beat and raise result should spark renewed buying interest in the stock.
Goldman Sachs stock is near flat on Tuesday, despite missing on earnings and revenue expectations. Here's how to trade GS stock from here.
Johnson & Johnson delivered a beat-and-raise quarter, which is just what the doctor ordered for a breakout. Let's look at the charts of JNJ stock.
ABBV stock is still around our average cost basis price, and with GS we believe there is justification to buy back the remaining 25 shares we previously sold higher.
Among the 160 or so reports set for this week, 52 will be from S&P 500 companies and seven are Dow 30 constituents.
Jeff fills in for Jim and discusses this morning's earnings from Goldman Sachs, Citigroup, JP Morgan, UnitedHealth Group, and much more!
Johnson & Johnson posted stronger-than-expected third quarter earnings Tuesday, and lifted its full-year sales and profit guidance, as pharmaceutical revenues surprised to the upside.
Global stocks traded cautiously higher Tuesday, while U.S. equity futures pointed to a firmer open on Wall Street, as investors prepped for a two-day wave of bank earnings that could define the third quarter reporting season while paring risk positions amid lingering questions over the fate trade talks between Washington and Beijing.
Citigroup and Lululemon are on the radar this morning.
U.S. stock futures rise as investors prep for a two-day wave of bank earnings; Citigroup, JPMorgan Chase, Wells Fargo and Goldman Sachs report earnings Tuesday; the UAW plans a call Thursday to update striking workers on the status of talks with General Motors.
- Sales of $20.7 billion reflecting growth of 1.9%, operational growth of 3.2%* and adjusted operational growth of 5.2%*
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.